Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-25-087546

Chief Medical Officer gave up 6,448 shares (to pay taxes)

  • Chief Medical Officer acquired 12,697 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer 2025-09-02 Option exercise +12,697 111,857 D
GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer 2025-09-02 Shares withheld for taxes −6,448 $2.19 $14,121 105,409 D
Derivatives
GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer 2025-09-02 Option exercise · Restricted Stock Units −3,907 7,813 D
GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer 2025-09-02 Option exercise · Restricted Stock Units −8,790 52,738 D
Loading xslF345X05/tm2525186-2_4seq1.xml…